Ayşe Özlem METE, Mete Gürol UĞUR, Mustafa NAMIDURU, İlkay KARAOĞLAN, Berna KAYA UĞUR

Evaluation of the relationship between human brucellosisand pregnancy loss

Aim: Brucellosis is a zoonotic infection caused by bacteria of the genus Brucella. The disease causes genitourinary systeminvolvement and abortion, which is the most critical complication of the disease, in cattle. Although it is known to cause spontaneousabortion, preterm birth and intrauterine death in humans, the number of systematic studies on the subject is limited. This studycompared the patients who experienced pregnancy loss and women who carried their pregnancy to term without any problems interms of serology for brucellosis in our region which is an endemic region. Materials and Methods: The study was conducted in the Clinic of the Department of Obstetrics and Gynecology in GaziantepUniversity Hospital between August 2012-June 2013. The study was conducted with 71 patients who experienced intrauterinepregnancy loss and 109 women who carried their pregnancy to term without any problems as the control group, wherein all subjectswere aged between 18 and 40. These two groups were in a similar age group and had a similar gestational age. Results: There were 4 (5,6%) subjects who were brucella-positive in the patient group and 1 (0,9%) subjects who were brucella positive in the control group according to the serology for brucellosis. C-reactive protein, erythrocyte sedimentation rate, aspartateaminotransferase, abortus, and parity were significantly high in women who experienced pregnancy loss (p

PDF

___

1. Greenfield RA, Drevets DA, Machado LJ, et al. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002;323:299-315.
2. Ali MA, James OC, Mohamed AA, et al. Etiologic Agents of Fever of Unknown Origin Among Patients Attending Mnazi Mmoja Hospital, Zanzibar. J Community Health 2020;45:1073-80.
3. Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91-9.
4. Godfroid J, Cloeckaert A, Liautard JP, et al. From the discovery of the Malta fever’s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 2005;36:313-26.
5. Colmenero JD, Reguera JM, Cabrera FP, et al. Serology, clinical manifestations and treatment of brucellosis in diff erent age groups. Infection 1990;18:152-6.
6. Young EJ. Brucella species. In Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases (7th ed). Philadelphia: Churchill Livingstone 2010:2921-5.
7. Mete A, Mete AO, Kimyon S, et al. Unilateral Brucella dacryoadenitis. EurJTher 2018;24:61-3.
8. Hasanjani Roushan MR, Mohrez M, et al. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 2004;132:1109-14.
9. Baud G, Greub G. Intracellular bacteria and adverse pregnancy outcomes. Clin Microbiol Infect 2011;17: 1312-22
10. Kurdoglu M, Adali E, Kurdoglu Z, et al. Brucellosis in. pregnancy: a 6- year clinical analysis. Arch Gynecol Obstet 2010;281:201-6.
11. Inan A, Erdem H, Elaldi N, et al. Brucellosis in pregnancy: results of multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 2019;38:1261-8.
12. Elkiran O, Kocak G, Karakurt C, et al. Brucella myocarditis in a 3-month-old: probable transplacental transmission. Ann Trop Paediatr 2010;30:225-8.
13. Corbel MJ. Brucellosis: An overview. Emerg Infect Dis 1997;3:213-21.
14. Yagupsky B, Baron EJ. Laboratory exposures to Brucella and implications for bioterrorism. Emerg Infect Dis 2005;11:1180-5.
15. Texas Animal Health Commission. Brucellosis Eradication Working Group: Report and recommendations to the Texas Animal Health Commission. Presented in Austin 2007.
16. Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 2007;25:188-202.
17. Cetin ET, Coral B, Bilgic A, et al. Determination of the incidence of Human brucellosis in Turkey. Doga-Turk J Med Sci 1990;14:324-34
18. Ceylan E, Irmak H, Buzgan T, et al. Some of the provinces of Van brucellosis in human and animal populations in villages seroprevalence. Van Med J 2003;10:1-5.
19. Khan MY, Mah MW, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis 2001;32:1172-7.
20. Young EJ. Human brucellosis. Rev Infect Dis 1983; 5:821-42.
21. Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas and Bennett’s principles and practice of infectious diseases (4th ed). New York: Churchill Livingstone, 1995:2053-60.
22. Keppie J, Wıllıams AE, Wıtt K, et al. The Role Of Erythritol In The Tissue Localization Of The Brucellae. Br J Exp Pathol 1965;46:104-8.
23. Nassaji M, Rahbar N, Ghorban R, et al. The role of Brucella infection among women with spontaneous abortion in an endemic region. , J Turkish-German Gynecol Assoc 2008;9:20-3.
24. Kledmanee K, Liabsuetrakul T, Sretrirutchai S. Risk of adverse pregnancy outcomes and seroprevalence for brucellosis in pregnant women exposed to goats or raw goat products in southern Thailand: a prospective cohort study. BMC Pregnancy Childbirth 2019;19:118.
25. Simor AE, Karmali MA, Jadavji T, et al. Abortion and perinatal sepsis associated with campylobacter infection. Rev Infect Dis 1986;8:397-402.
26. Sauerwein RW, Bisseling J, Horrevorts AM. Septic abortion associated with Campylobacter fetus subspecies fetus infection: case report and review of the literature. Infection 1993;21:331-3.
27. Farrell DJ, Harris MT. A case of intrauterine fetal death associated with maternal Campylobacter coli bacteraemia. Aust N Z J Obstet Gynaecol 1992;32: 172-4.
28. Roushan MRH, Baiani M, Asnafi N, et al. Outcomes of 19 pregnant women with brucellosis in Babol, northern Iran. Trans R Soc Trop Med Hyg 2011;105:540-2.
29. Urbaschek B. Motility-Promoting Effect of the Brucella Abortus and Brucella Melitensis Endotoxin on the Smooth Uterine Muscle. Nature 1964;202:883-4.
30. Madkour MM. Pregnancy and brucellosis. In: Madkour MM (eds) Brucellosis (1st ed). Butterworth, London, 1989;197-204.
31. Ghanem-Zoubi N, Eljay SP, Anis E, et al. Association between human brucellosis and adverse pregnancy outcome: a cross-sectional population-based study. Eur J Clin Microbiol Infect Dis 2018;37:883-8.
32. Buzgan T, Karahocagil MK, Irmak H, et al. Clinical manifestations and complications in 1028 cases of brucellosis: A retrospective evaluation and review of the litrature. Int J Infect Dis 2010;14:469-78.
33. Ganado W, Bannister W. Bacteraemia in human brucellosis. BMJ 1960;1:601-3.
34. Sarafidis K, Agakidis C, Diamanit E, et al. Congenital brucellosis: a rare cause of respiratory distress in neonates. Am J Perinatol 2007;24:409-12.
35. Abo-Shehada, Abu-Halavel. Seroprevalance of Brucella species among women with miscarriage in Jordan. EMJH 2011;7:871-4.
36. Doganay M, Alp Mese E, Topçu AW, et al. Infection Diseases and Microbiology (3rd Edition). Istanbul: Nobel Medical Publishing, 2008:897-909.
37. Karcaaltincaba D, Sencan I, Kandemir O, et al. Does brucellosis in human pregnancy increase abortion risk? Presentation of two cases and review of literature. J Obstet Gynaecol Res 2010;36:418-23.
38. Mancini FR, Bella A, Grazıanı C, et al. Trends of human brucellosis in Italy, 1998-2010. Epidemiol Infect. 2014: 142;1188-95.